NCT07549100
- Conditions
- Locally Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- Shandong Provincial Hospital Jinan, Shandong, China
Clinical trial condition
Locally Advanced Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Locally Advanced Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
10 public trials
5 recruiting studies
Locally Advanced Esophageal Squamous Cell Carcinoma trial results
NCT06356688
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- the First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06843889
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Baiyun District, China
Recruiting
Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06907602
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Recruiting
Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)
NCT06187597
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Mian Xi Guangzhou, Guangdong, China
Enrolling by Invitation
Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06715501
- Conditions
- II-IIIB Stages, Locally Advanced Esophageal Squamous Cell Carcinoma
- Locations
-
- First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
Not Yet Recruiting
Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06426797
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
Not specified
NCT03914443
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- National Cancer Center Hospital Tokyo, Japan
Active, Not Recruiting
Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)
NCT05520619
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Mian Xi Guangzhou, Guangdong, China
Active, Not Recruiting
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
NCT06342167
- Conditions
- Concurrent Chemoradiotherapy, Immunonutrition, Locally Advanced Esophageal Squamous Cell Carcinoma, +2 more
- Locations
-
- Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
- Department of Radiation Oncology，Clinical Oncology School of Fujian Medical University，Fujian Cancer Hospital Fujian, China
- Department of Oncology, Affiliated Hospital, Hebei University of Engineering Handan, Hebei, China
- Department 1st of Radiation Oncology, Anyang Tumor Hospital Anyang, Henan, China